<DOC>
	<DOCNO>NCT01548326</DOCNO>
	<brief_summary>The purpose study determine whether short-term Atorvastatin increase immunity response hepatitis B vaccination vaccine Nonresponders .</brief_summary>
	<brief_title>Effects Short-term Atorvastatin Treatment Vaccination Efficacy Nonresponder Persons Hepatitis B Vaccine</brief_title>
	<detailed_description>20 person vaccinated individual HBsAb &lt; 10 3 dose hepatitis B vaccination call Nonresponders randomly allocate 2 group . one group receive short-term Atorvastatin group receive placebo.both group vaccinate hepatitis B vaccine immunity response measure .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Previous 3 dose hepatitis B vaccination Negative HBc Ab Negative HBs Ag HBs Ab le 10 ELIZA positive serologic evidence Hepatitis B infection Chronic use Atorvastatin Immunosuppressive Disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Vaccination Failure</keyword>
	<keyword>Nonresponder</keyword>
	<keyword>Hepatitis B virus</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Immunization viral Hepatitis</keyword>
</DOC>